Drugs.com: Effect of cancer treatment on COVID-19 mortality
September 22, 2020
Drugs.com covers UC research looking at mortality in patients with cancer and COVID-19.
Article has no nextliveshere tags assigned
Article has no topics tags assigned
Article has no colleges tags assigned
Article has no audiences tags assigned
Article has no units tags assigned
Contacts are empty
These messages will display in edit mode only.
DAAP hosts second annual DAAPX symposium virtually
August 26, 2020
Event Information (passed)
University of Cincinnati alumni, friends and community members are invited to a virtual day of face-paced, TEDTalk-style presentations on diverse projects and experiences from the College of Design, Architecture, Art, and Planning alumni across all majors and degrees. Originally scheduled for April, organizers are excited to be shifting presentations online so participants can tune in live from anywhere in the world.
This edition of DAAPX tackles the topic of experiential design and the work of DAAP alumni that is created for and influences or impacts people. Last fall, the DAAP Alumni Network accepted proposals for presentations that tell a story about a project that was designed with an individual’s or group’s experience in mind, offering the opportunity to see select presentations that are centered on that human experience.
From the design and build of the Los Angeles FC Soccer stadium to the use of empathy as a driver for design at the Cleveland Clinic to the reopening of exhibits at the iconic Cincinnati Museum Center (to name a few), this will be a morning you won’t want to miss.
This virtual event is complimentary. Be sure to register so you receive the official streaming link the week of the event.
DAAPX Features:
- Adam Feld, MDES ’13 | Sponsored Projects Can Be a Bunch of Bull
- Rebecca W. Aamodt, BSDE ’87 | Redefining Experiences in the World of Event Design
- Adam Rosa, BUP ’00 | Youth Engagement in Planning and Urban Design
- Sam Tallo, BSID ’14 | Designing for Agile Work and Employee Experience
- Eric Blyth, BSARC ’13, Justin West, Sam Ferris-Morris | In Place of Forgetting: Engaging with Archives
- Carl Sterner, MARCH ’08 | Summer House, Winter House: Design for Thermal Delight
- Fern Linzinger, BSARC ’08, MARCH ’10, and Rachael Kroth, BSARC ’13 | “It’s not Spelunking; the correct term is Caving…” and other lessons from updating a fan-favorite exhibit
- Joel Spearman, BSARC ’05, MARCH, ’07 | LAFC: Defining a Team
- Joseph Strauss, BARC ’75 | Empathy: A Driver for Healthcare Facility Design
- Geoff Baldwin, BSDE ’06 | Proof of Concept: Stories from the intersection of prototyping and vulnerability
- Kelley Kolar, BSDE ’86 | 30/30: Thirty Years of Positive Impact
- Michael Damschroder, BSDE ’86 | The Sports Legends Experience: Bringing Sports and History to Children of ALL Ages
- Derrick Woodham, Faculty Emeritus, School of Art | DAAP in Activeworlds
Related Stories
Silk offers homemade solution for COVID-19 prevention
September 22, 2020
With personal protective equipment still in short supply, researchers at the University of Cincinnati examined what common household fabrics might work best as a face covering. They found that silk is breathable, washable and moisture better than cotton or synthetics.
UC researchers to study drug’s effects on COVID-19 patients
September 22, 2020
Researchers at the University of Cincinnati and UC Health will host a Phase 2 clinical trial (NCT04511650) to examine the effects of a drug that targets blood vessel inflammation and injury in patients with COVID-19. They will study the effects of razuprotafib, an investigational drug that activates a key pathway for stabilizing blood vessels in the lung and other organs in patients with moderate to severe cases of the respiratory illness caused by the novel coronavirus SARS-CoV-2. The drug may prevent and treat respiratory distress in COVID-19 patients. The Phase 2 clinical trial will assess safety, tolerability and efficacy of razuprotafib.